D
Dynasty Gene
Dynasty Gene is a Developer of synthetic biology technology and provider of biotechnology consulting services
About Dynasty Gene
Based in Shanghai, China, Dynasty Gene operates as a manufacturer of nucleic acid synthesis products. The company serves a clientele of researchers and biotech companies engaged in molecular diagnostics, synthetic biology, and biomedical research. Its core offering is a platform technology that leverages a 3D inkjet printing process for ultra-high-throughput in situ synthesis of DNA and RNA. This method is engineered to provide high-precision, cost-effective, and scalable production of genetic sequences for a variety of life science applications.
The company's primary industry is classified as Diagnostic Equipment. Dynasty Gene's operational model focuses on supplying essential tools for advanced biological research and development. The business has attracted notable investment from firms including Boyu Capital, ByteDance, Sirona Capital, and MSA Capital, among others. With a team of 29 employees, the firm is positioned to support the growing demands within the biotechnology sector.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Huangpu, China
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Volcanics Venture
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dynasty Gene on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dynasty Gene on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.